中晚期肝细胞癌介入治疗的进展及前景

Progress and prospects of interventional therapy for advanced hepatocellular carcinoma

肝细胞癌(HCC)是国内常见恶性肿瘤之一,严重威胁人民身体健康。外科手术切除病灶是HCC患者获得长期生存的主要手段之一,但有部分患者在初诊时已处于中晚期而不可行手术治疗。近年来介入治疗不断发展,在HCC领域取得诸多优异成绩,合理应用可有效延长患者生存时间。本文就血管介入治疗在中晚期HCC治疗领域中的临床应用研究进展和前景进行论述。

Hepatocellular carcinoma(HCC)is one of the common malignant tumors in China,which seriously threatens the health.Surgical resection of HCC lesions is one of the main means to achieve long-term survival,but some patients are already at the middle or late stage since the time of initial diagnosis and surgical resection is not feasible.In recent years,interventional therapy has continuously developed and achieved excellent achievements in the field of HCC,and reasonable application can effectively prolong the survival time of patients.This article discusses the clinical research progress and prospects of vascular interventional therapy in the treatment of advanced HCC.